233 results about "Atrophic mucosa" patented technology

Disclosed is an inorganic medicine, particularly modified montmorillonite, method for preparing the same and use thereof. The said modified montmorillonite means that dioctahedron of natural montmorillonite is not destroyed and basic chemical composition for the same is not changed, and the microstructure stacked from dioctahedron layer is changed to decrease the thickness of stacking layer and to expose and increase the end face charge and the interlayer charge of montmorillonite, thereby resulting in its lower degree of C axis order. The present medical use of montmorillonite is thus significantly strengthened, particularly the reversal treatment effect on chronic atrophic gastritis. Also disclosed are a medicine composition containing modified montmorillonite and the reversal treatment effect of natural montmorillonite on chronic atrophic gastritis.

The invention discloses a traditional Chinese medicinal formula for treating gastropathy. The formula comprises Radix Codonopsis, Radix Astragali, Radix Pseudostellariae, Mythic Fungus, white peony root, Chinese angelica, Rhizoma Atractylodis Macrocephalae, Chinese yam, haw, malt, medicated leaven, Atractylodes lancea, Panax Notoginseng, radix bupleuri, Rhizoma Cyperi, Rhizoma Corydalis, cuttlefish bone, Radix et Rhizoma Nardostachyos, Immature Bitter Orange, Poria cocos, Villous Amomum Fruit, dried orange peel, Radix Aucklandiae, chicken's gizzard membrane, cortex magnoliae officinalis and licorice according to the monarch, minister, assistant and guide of the traditional Chinese medicinal science. The monarch medicines comprise the Radix Codonopsis, the Radix Pseudostellariae, the Radix Astragali and the Mythic Fungus; the minister medicines comprise the white peony root, the Chinese angelica, the Rhizoma Atractylodis Macrocephalae, the Chinese yam, the haw, the malt, the medicated leaven, the Atractylodes lancea, the Panax Notoginseng, the radix bupleuri, the Rhizoma Cyperi, the Rhizoma Corydalis, the cuttlefish bone and the Radix et Rhizoma Nardostachyos; the assistant medicines comprise the Immature Bitter Orange, the Poria cocos, the Villous Amomum Fruit, the dried orange peel, the Radix Aucklandiae, the chicken's gizzard membrane and the cortex magnoliae officinalis; and the guide medicine is the licorice. The medicine of the formula has the efficacies of liver smoothing and depression resolving, center supplementing and qi boosting, qi moving and stomach harmonizing, and dampness eliminating and spleen invigorating, has special curative effects on chronic gastritis (comprising superficial gastritis, erosive gastritis and atrophic gastritis), gastric ulcer and duodenal ulcer, and has the advantages of short treatment course, fast effectiveness, and reaching of the effective rate of 98%.

The present invention discloses a prescription for treating gastropathy, pertaining to a Chinese medicine. The recipe includes 10 chunhua, 10 finger citron flower, 10 official magnolia flower, 10 green tangerine peel, 10 zhixiangfu, 10 heterophylly falsestarwort root, 15 fried largehead atractylode with earth, 6 prepared pinellia tuber, 12 white poria, 10 dried citrus peel, 6 liquorice, 10 gongying, 12 bullbrier, 10 lobed kudzuvine, 10 hovenia dulcis, 15 parched Chinese radish seed, 10 glabrous greenbrier rhizome, 12 white peony root, 10 Chinese angelica root, 15 radix adenophorae, 12 dwarf lilyturf , 10 nobile dendrobium, 6 bamboo shavings, 10 virgate wormwood herb, 6 bupleurum falcatum, 6 parched gentian with wine, 10 ground ivy, 6 jinlingzi, 10 xuanhusuo, 6 betelnut, 10 zhichuanjun, 15 chicken's gizzard skin, 15 fried barley sprout and 10 citrus medica, as well as three pieces of gingers and four jujubes as pharmacal. The prescription has good curative effect on superficial gastritis, atrophic gastritis, erosive gastritis, hypertrophic gastritis, bile reflux gastritis and gastric ulcer.

The invention relates to a Chinese traditional medicine and a preparation method thereof, in particular to a pure Chinese traditional medicine preventing preparation which can effectively treat outdated, superficial, and atrophic gastritis, ulcer, edema, and acute and chronic gastroenteritis, hepatocholangeitis, and malignancy, and can improve the immunity of the patients, and a preparation method thereof. The herbal preparation is composed of more than 100 pure Chinese traditional medicines according to the proportioning by weight: dzho milk made calcite, zuota, jade, coral, pearl, tabasheer, saffron, clove, nutmeg, cardamom, Fructus Tsaoko, bezoar, Phytolacca acinosa, yellow corydalis, iris, Panax pseudoginseng, coriander, rutabaga, double-blossom groundsel, red sal ammoniac, purple sal ammoniac, Sikkimese rock astragalus root, stenophyllous ground touching plum, Tibetan arris vegetable, Himalayas red Jessamine, caltrop, Nangjuguique, veronica, etc. The preparation method includes six procedures of crushing, mixing, making pill, polishing, and packaging. The Chinese traditional medicine of the invention has notable curative effect, simple medicament form, and simple production process, and is worthy to be popularized and applied.

The invention discloses a Chinese medicine composite for treating chronic atrophic gastritis and a preparation method thereof. The Chinese medicine composite mainly comprises the following active pharmaceutical ingredients: jobstears seed, rhizoma dioscoreae, pericarpium citri reticulatae, fructus aurantii immaturus, radix aristolochiae, ligusticum chuanxiong, Lignum aquilariae resinatum, rhizoma corydalis, stir-fried frankincense, stir-fried myrrh, pericarpium citri reticulatae viride, radix scrophulariae, rhizoma cyperi, styrax, radix trichosanthis, radix rehmanniae preparata, peach seed, safflower, medicated leaven, fructus setariae germinatus, dandelion, honeysuckle flower, rhizoma coptidis, radix et rhizoma rhei, radish seed, rhizoma curcumae longae, grassleaf sweetflag rhizome, cortex magnoliae officinalis and tuckahoe, and the like. The Chinese medicine composite can be prepared to be any common oral preparation according to the conventional Chinese medicine preparation method. The Chinese medicine composite can obviously improve abdominal distention that is manifest due to more food intake, tastelessness and insipidity, vague pain and complaint in the gastric cavity, lassitude, athrepsy, anorexia, anaemia and the like and the complications including gastric bleeding, gastrelcosis, anaemia and gastric cancer, and the like, which has definite clinical effect, obvious curative effect and fast desired effect.

The invention discloses a vascular four-dimensional reconstruction method in a NOT gate-controlled ICUS (intravascular ultrasound) image sequence. The method comprises the following steps: accurately positioning an ultrasonic catheter retracement path by utilizing a pair of approximate orthorhombic CAG (chronic atrophic gastritis) image sequences collected with an ICUS image synchronously; carrying out four-dimensional reconstruction on a morphological structure of a target vessel section containing possibly existing plaques through combining the cross section information of a vessel lomen extracted from the ICUS image; and reproducing true forms of coronary vessels at each time phase in a cardiac cycle. With the adoption of the vascular four-dimensional reconstruction method in the NOT gate-controlled ICUS image sequence, the four-dimensional reconstruction of the morphological structure of a coronary artery target vessel section containing the possibly existing plaques is realized, the true forms of the target vessel section at different time phases in the cardiac cycle can be comprehensively and truly reflected; and more reliable accordance can be provided for clinical diagnosis and treatment of coronary arteriesarteriosclerosis osteolytic lesions and research of biomechanical characteristics of coronary artery vascular tissues and the like. The method does not need an ECG-gating acquisition device, and also does not need ECG signals, so that the interventional examination time is greatly shortened, and the requirements on the original image data are reduced.

A Chinese medicine in the form of particles for treating chronic gastritis and chronic atrophic gastritis and preventing stomach cancer is prepared from 10 Chinese-medicinal materials including notoginseng, white peony root, dandelion herb, liquorice root, etc. Its preparing process is also disclosed.

The invention provides a medicine composition for treating chronic atrophic gastritis, which has the advantages of obvious curative effect and convenient carrying. The medicine composition can not only improve various clinical symptoms of the chronic atrophic gastritis, but also improve intestinal metaplasia and heterotypic hyperplasia accompanying the chronic atrophic gastritis, thereby realizing stomach cancer prevention by the medicine. The medicine composition is prepared by the extracts of roasted milkvetch root, radix codonopsis pilosulae, dried orange peel, nutagrass flatsedge rhizome, white peony root, Chinese yam, black plum and liquorice; the preparation process is simple and is suitable for mass production; the clinical tests show that the preparation 'stomach nourishing granules' prepared by the technical proposal can fully improve various symptoms of the chronic atrophic gastritis, achieve the aim of clinical curing, and has more stable efficacies in particular to the chronic atrophic gastritis caused by weakness of the spleen and the stomach or weakness of the spleen and the stomach and qi stasis.

The invention relates to a method for building a spleen-deficiency chronic atrophic gastritis gastric precancerous lesions animal model. The method is based on the existing spleen-deficiency rat model and the existing chronic atrophic gastritis rat model and is used for building the animal model through united copy of free drinking of N-methyl-N '-nitro-N -nitrosoguanidine (MNNG) solution, irregular eating and purgation. The method comprises the following specific steps of: preparing 10mg / L MNNG storage solution by utilizing sterilized tap water, preparing 80 to 200 mug / mL MNNG solution in temporary use to substitute the drinking water to be drunk freely by the rats, and adopting the free drinking of MNNG as the beginning of the modeling; copying a spleen-deficiency syndrome through irregular eating and improved purgation way, feeding the rats on alternate days since the fifth week after the modeling, and utilizing qi-activating decoction for gavage in a dose of 1 to 3ml per rat every day in the seventh weak; and continuing the modeling for 12 weeks. The animal model built through the method is identical to or similar with the clinical syndrome and physical signs of middle-late lesions in chronic atrophic gastritis. After being verified in repeatedly modeling, the method has good repeatability and good stability. The built model is suitable for selecting traditional Chinese medicine for treating the chronic atrophic gastritis through a traditional Chinese medicine spleen treatment method.

The invention discloses a Chinese medicinal formula for treating atrophic gastritis and precancerous lesion. The effective ingredients comprise the following Chinese medicinal herbs by weight: 10 to 50 grams of sauted pilose asiabell root, 10 to 50 grams of sauted large-headed atractylodes rhizome, 10 to 30 grams of tuckahoe, 5 to 20 grams of pinellia tuber, 5 to 20 grams of dried orange peel, 3 to 10 grams of raw licorice root, 5 to 15 grams of root powder of pseudo-ginseng, 5 to 20 grams of zedoary, 5 to 20 grams of Zhejiang fritillaria bulb, 15 to 60 grams of spreading hedyotis herb, 10 to 60 grams of hairy-vein agrimonia herb and bud, 10 to 60 grams of barbed skullcap herb, 5 to 20 grams of fruit of princesplume ladysthumb and 5 to 20 grams of creeping fig fruit. The Chinese medicinal formula has the effects of tonifying spleen, regulating qi, dissipating blood stasis and detoxifying, treats both principal and secondary aspects of diseases aiming at the pathogenesis of the chronic atrophic gastritis and precancerous lesion, has low recurrence rate after healing and good short-term and long-term curative effect, and has not toxic or side effect.

The invention relates to the field of immunodetection, in particular to a chemiluminescent quantitative determination kit for pepsinogen II and a preparation method of the chemiluminescent quantitative determination kit. The chemiluminescent quantitative determination kit for the pepsinogen II comprises (1) a pepsinogen II antibody coated micropore plate, (2) an HRP-labeled pepsinogen II antibody, (3) series pepsinogen II calibration materials diluted by a calibration material diluent, (4) a luminescent substrate A, (5) a luminescent substrate B and (6) a solid washing liquid. The kit disclosed by the invention is capable of detecting the content of the pepsinogen II in serum; and the level of the pepsinogen II in the serum is in positively relevant to atrophic gastritis and peptic ulcer; in treatment of peptic ulcer, the treatment result can be judged by monitoring the change of the degermed pepsinogen; and the chemiluminescent quantitative determination kit is noninvasive, simple and fast in detection method, high in sensitivity, wide in detection range and the like.

The invention discloses a traditional Chinese medicine composition for atrophic gastritis, which comprises the following raw materials by weight: 18-22 parts of radix codonopsis, 18-22 parts of radix astragali preparata, 10-20 parts of concha arcae, 5-7 parts of kaempfer dutchmanspipe root, 1-3 parts of rhizome of david woodbetony, 10-12 parts of combined spicebush root, 3-9 parts of citron, 8-12 parts of poria cocos, 5-7 parts of platycarya strobilacea, 6-8 parts of Chinese angelica, 2-4 parts of fructus amomi, 2-4 parts of coptis chinensis, 8-12 parts of dry ginger, 14-16 parts of rhizoma nardostachyos, 18-22 parts of malt, 8-12 parts of curcuma zedoary, 8-12 parts of bletilla striata, 8-12 parts of sargentg loryvine stem, 5-8 parts of fructus evodiae and 5-8 parts of amomum cardamomum. The traditional Chinese medicine composition provided by the present invention has the efficacy of invigorating spleen and qi, adjusting qi and nourishing blood, and calming heart and promoting blood stasis; and the traditional Chinese medicine composition for atrophic gastritis has the advantages of good curative effect and fast effectiveness.

The composite Chinese medicine for treating gastrointestinal diseases may be decoction, bolus or granule and is prepared with Mantianxue, red sage, white atractylodes rhizome and Loushanglou. Owing to red sage with functions of promoting blood circulation, hemostasis and eliminating blood stasis and Mantianxue and Loushanglou with powerful functions of clearing away heat and toxic matter and killing spirillum, the medicine has obvious curative effect on gastrointestinal ulcer, atrophic gastritis and ulcerative colitis and no side effect.

The invention discloses a stomachache curing powder and the preparing method thereof, prepared of the following raw materials in weight shares: White Paeony Root 4-8 shares, Rhizoma Cyperi 3-6 shares ,costus root 2-4 shares,Rhizoma Corydalis 3-6 shares, Corium stomachichum galli 3-6 shares, Cuttlebone 6-12 shares,Liquorice Root 2-4 shares, Thunberg Fritillary Bulb 3- 6 shares, and Sanchi 1.6-3.2 shares. And its preparing method includes a process flow as follows: taking the raw materials, selecting and rinsing clean parts and drying them at low temperature, crushing and passing through 100-mesh sieve, sterilizing, capsulizing, and checking the quality. It can promote the secretion of gastric juice and obviously raise the acidity of gastric juice and the activity of pepsin and steapsin, promote concrescence of gastric ulcer, strenghten digestion, and effectively cure patients with atrophic gastritis.

The invention belongs to the technical field of traditional Chinese medicines and relates to oral liquid for treating chronic atrophic gastritis. The oral liquid is prepared by the following components in parts by weight: 10 parts of Zhejiang white atractylodes rhizome, 15 parts of poria cocos, 10 parts of orange peel, 10 parts of pinellia tenata breit, 10 parts of vinegar rhizoma cyperi, 10 parts of fructus amomi, 10 parts of mangnolia officinalis, 10 parts of vinegar curcuma aromatic, 15 parts of artemisia anomala, 6 parts of cassia twig, 10 parts of rhizoma corydalis, 10 parts of hawthorn, 10 parts of roasted malt, 10 parts of roasted medicated leaven, 10 parts of lindera aggregate, 15 parts of radix paeoniae alba, 12 parts of radix pseudostellariae and 3 parts of liquorice. The oral liquid provided by the invention has the effects of relieving inflammatory cell infiltration, regulating cellular immunity and humoral immunity function, restraining the activity of pepsinogen to promote proliferation and recovery thereof, strengthening barrier protection function of the mucosa, regulating gastrointestinal motility, increasing permeability of gastric mucosa, improving blood circulation of the mucosa, promoting atrophic glands to recover, and delaying or reversing progression of diseases.

The invention discloses a Chinese herb preparation for treating chronic atrophic gastritis. The preparation comprises, by weight, 9-18 parts of codonopsis pilosula, 6-15 parts of fried bighead atractylodes rhizome, 6-15 parts of poria cocos, 3-12 parts of pericarpium citri reticulatae, 3-12 parts of pericarpium citri reticulatae, 3-12 parts of honey-fried licorice root 3-12 parts of processed rhizoma pinelliae, 2-11 parts of rhizoma zingiberis, 3-12 parts of cassia twig, 9-18 parts of parched white peony root, 3-12 parts of caulis perllae, 12-21 parts of cuttle bone, 6-15 parts of fried malt, 6-15 parts of fried rice sprout and 2-5 parts of coptis chinensis. The invention further discloses a preparing method of the Chinese herb preparation. The Chinese herb preparation has the advantages of being accurate in curative effect, few in toxic and side effect, convenient to take and low in cost compared with similar medicine on the market in treating the chronic atrophic gastritis and the precancer lesion, and the compliance of patients is good.

The invention relates to a Chinese patent medicine for treating gastric diseases. The Chinese patent medicine is characterized in that the medical prescription comprises prepared milkvetch root, cassia twig, medcinal evodia fruit, cassia bark, cuttlebone, peach seed, safflower, Chinese angelica, Szechuan lovage rhizome, red paeony root, salvia miltiorrhiza root, tree peony bark, rhizoma corydalis, wenyujin concise rhizome, common burreed rhizome, zedoary, leech, costustoot, bitter orange, combined spicebush root, golden thread, prepared liquoric root and rehmannia root. Compared with the prior Chinese patent medicines for treating the gastric diseases, the Chinese patent medicine of the invention has more reasonable formula, the synergy among various medicine components can promote the blood circulation of gastrointestinal mucosa, can rapidly recover the inflammation parts and the gastric ulcer surfaces thereof and can achieve the treatment effect on activating blood circulation, activating qi-flowing, relieving pain, nourishing qi, strengthening spleen and regulating spleen and stomach, the efficacy is remarkable and the Chinese patent medicine has no toxicity or side effects; the formula has the efficiency on swallowing acid, warming stomach, benefiting qi for warming stomach, dispelling cold, activating qi, activating blood circulation and relieving pain. The Chinese patent medicine is mainly used for gastric ulcer and duodenal ulcer caused by deficient cold of spleen and stomach, cold coagulation and blood stasis, as well as chronic atrophic gastritis.

The invention relates to a granulated preparation for treating gastropathy and process for preparation, wherein the preparation is prepared mainly from lily bulb, poria cocos, scrophularia root, Ligusticum wallichii, chicken's gizzard-skin, spicebush root, oriental water plantain rhizome, lilyturf root, notoginseng, white atractylodes rhizome, Chinese angelica root and right amount of auxiliary materials.

The invention belongs to the technical field of model building and evaluating methods, particularly relates to a building and evaluating method of a chronic atrophic gastritis rat model and mainly solves the technical problem that existing building and evaluating methods of the chronic atrophic gastritis rat model are low in accuracy, high in cost and time consuming and labor consuming. Technology of metabonomics is adopted, and a metabolic profile dynamic trajectory spectrum is acquired by analyzing changes in endogenous metabolite in organism end product urine before and after model building. In addition, MestReNova software is used to process all NR spectra to obtain integral data, statistical analysis on content of 18 biomarkers is combined, and a rule that changes in integral average value of the 18 biomarkers in the urine before and after model building reflect changing tendency of urine metabolic trajectory of rats with chronic atrophic gastritis to certain extent is found, so that the chronic atrophic gastritis model is evaluated in a targeted manner.

The invention discloses a traditional Chinese medicine preparation for treating chronic atrophic gastritis. The traditional Chinese medicine preparation is prepared from the following ingredients in parts by weight: 10-20 parts of radix bupleuri, 10-20 parts of bighead atractylodes rhizome, 10-20 parts of astragalus membranaceus, 10-20 parts of fructus aurantii, 10-20 parts of corydalis tuber, 10-20 parts of sculellaria barbata, 8-18 parts of fructus amomi, 8-18 parts of agastache rugosus, 8-18 parts of fingered citron, 8-18 parts of radix paeoniae rubra, 8-18 parts of radix paeoniae alba, 8-18 parts of citron, 8-18 parts of armeniaca mume, 8-18 parts of concha arcae, 8-18 parts of fructus evodiae, 8-18 parts of radices trichosanthis, 8-18 parts of coxtex moutan, 8-18 parts of rhizoma bletillae, 8-18 parts of garden burnet, 8-18 parts of trogopterus dung, 20-40 parts of herba patriniae, 20-40 parts of oldenlandia diffusa, 2-12 parts of coptis chinensis, 2-12 parts of curcuma zedoary, 2-12 parts of scorpion and 2-12 parts of liquorice. The traditional Chinese medicine preparation is prepared by using traditional Chinese herbs as raw materials, selecting genuine medicinal materials and following the traditional processing method and has effects of soothing liver, regulating qi, strengthening spleen and stomach, removing heat from liver for nourishing the stomach, dissolving phlegm and dispersing blood stasis. Starting from regulating qi and blood of viscera, the traditional Chinese medicine preparation reflects the whole concept of traditional Chinese medicine and the drug use characteristic of treatment based on syndrome differentiation, thereby removing liver depression, spleen deficiency, stagnated heat and blood stasis, and achieving the purpose of curing chronic atrophic gastritis.

The invention provides a Chinese medicament for treating atrophic gastritis and a preparation method thereof, and belongs to the technical field of Chinese medicament preparation. The Chinese medicament is prepared from natural Chinese herbal medicines as raw material prescription, and is characterized by comprising the following natural Chinese herbal medicines in parts by weight: 20 to 40 parts of astragalus mongholicus, 15 to 30 parts of raw rehmannia root, 10 to 20 parts of dwarf lilyturf tuber, 20 to 40 parts of white peony root, 10 to 20 parts of Chinese angelica, 8 to 16 parts of curcuma zedoary, 8 to 16 parts of corydalis tuber, and 3 to 6 parts of goldthread. Studies prove that the Chinese medicament has the functions of tonifying qi and nourishing yin, activating blood circulation to relieve pains, and treating chronic atrophic gastritis. The medicament has certain effects in improving symptoms, strengthening appetite, promoting digestion, relieving pains and the like, has no remarkable adverse response and high safety, is especially suitable for treating middle-aged and aged patients with chronic atrophic gastritis, and is rich in raw material sources and low in production cost, so that the economic burden of the patient can be greatly reduced by taking the medicament.

The present invention discloses a Chinese medicine compound for gastric mucosa protection and the preparation method. The plantaginis and the dandelion are taken as the raw materials in the compound, which are mixed with the excipient into an oral preparation after extraction with the ethanol subsiding method or the alcohol extraction and decompression of the recycling recycling. The present invention has synergistic interaction function. Single application of the plantaginis and the dandelion both have gastric mucosa protection function, which have a synergistic interaction function after combination and the treatment effect can increase dramatically. The technique process is simple and convenient. The active part can be maintained as much as possible. The present invention has a good protection and treatment function for the acute gastric mucosa injury, the chronic gastric mucosa injury and the chronic atrophic gastritis.

The present invention belongs to the field of Chinese herbal medicine, and provides a kind of chronic gastropathy treating Chinese medicine. The Chinese medicine has the functions of invigorating Qi and spleen, warming stomach, nourishing Yin, clearing away heat, keeping the adverse energy downwards, relieving gastric disorder, regulating Qi, etc and is used in treating chronic erosive gastritis, chronic atrophic gastritis, gastric cavity fullness feeling, stomachache and other chronic gastropathy. The present invention has high effective rate.

The invention relates to a Chinese medicine composition for treating chronic atrophic gastritis. The Chinese medicine composition is made from the following Chinese medicine raw materials in weight: 10-40 g of astragalus root, 10-40 g of radix pseudostellariae, 5-30 g of root of straight ladybell, 10-40 g of ophiopogon root, 5-25 g of fried atractylodes, 2-25 g of endothelium corneum gigeriae galli, 5-25 g of Chinese angelica, 5-20 g of safflower, 4-15 g of pseudo-ginseng, 5-30 g of dandelion, 4-15 g of dried ginger and 4-15 g of radix glycyrrhizae preparata. The Chinese medicine composition provided by the invention has the functions of tonifying Qi and warming middle-Jiao, promoting blood circulation to remove blood stasis, reinforcing the stomach and promoting the production of body fluid, and promoting blood circulation to promote tissue regeneration and has a reliable curative effect on the chronic atrophic gastritis. The composition is simple and convenient to prepare and is wide in medicinal resource; and in addition, the drug natures of the ingredients are moderate and have no side effects.

The invention relates to a Chinese traditional medical decoction for curing rheumatoid arthritis and background rheumatoid arthritis. The Chinese traditional medicine decoction is made of raw materials by weight ratios: 10 to 60 proportions of safflower, 20 to 100 proportions of twotooth achyranthes root, 10 to 40 proportions of eucommia bark, 30 to 100 proportions of angelica, 10 to 50 proportions of root of red rooted saliva, 15 to 25 proportions of ephedra herb, 25 to 40 proportions of radix angelicae pubescentis, 20 to 30 proportions of papaya and 600 to 1200 proportions of water. The invention has the advantages of supplementing the raw materials with each other and reaching the purposes of promoting blood circulation by removing blood stasis, smoothing the qi and blood, activating collateral flow and expelling wind and removing damness. The invention has a total effective rate of more than 90 percent for curing the rheumatoid arthritis and the background rheumatoid arthritis.

The invention discloses a traditional Chinese medicine for treating atrophic gastritis with intestinal metaplasia and atypical hyperplasia, which comprises rhizoma acori tatarinowii, herba pogostemonis, herba eupatorii, longhairy antenoron herb, stringy stonecrop herb, dandelion, fructus forsythia, dried tangerine, herba artemisiae scopariae, herba rabdosiae, scorpio, fructus gardeniae, Indian iphigenia bulb and the like. According to the traditional Chinese medicine disclosed by the invention, the components realize functions of eliminating turbid, removing toxin and activating blood, gastric mucosa inflammation can be eliminated, the blood flow of gastric mucosa is effectively improved, and the glands experiencing atrophy and intestinal metaplasia return to normal so as to reverse precancerous lesions of the gastric cancer.

The invention discloses a medicine for external application for treating rheumatoid arthritis and relates to medicine for treating rheumatoid arthritis. The preparation method of the medicine for external application comprises the following steps: (1) after ferrous powder, active carbon powder, salt, vermiculite, wormwood and lavender powder are ground into powder and are evenly mixed, the powder is subpackaged into bags which are sealed and are placed into a shady place for standby; (2) after futokadsura stem, orientavine, radix paeoniae lactiflorae, phellodendron, radix sileris and aconite are ground into powder and are evenly mixed, the powder is fixed on a colloid face and is prepared into a patch; and (3) an automatic heating layer and a medicine layer with various Chinese medicinal herbs are combined with the medicine layer with various Chinese medicinal herbs arranged in the inner side and the automatic heating layer arranged in the outer layer. The medicine for external application is a pure Chinese medicine preparation, has no toxic side effect, can be used for a long time, is light and practical, can be used easily, and is suitable for the old and the young. The efficacy of the medicine for external application is much better than that of similar medicine. The medicine saves time and labor, and has good effect for treating rheumatoid arthritis.

The invention relates to the technical field of traditional Chinese medicines, and in particular relates to a traditional Chinese medicine preparation for the treatment of chronic gastritis and a preparation method thereof. The traditional Chinese medicine preparation is characterized by comprising the following raw materials by weight percentage: 5-15% of codonopsis, 4-12% of tangerine peel, 5-15% of yam, 1-5% of dried ginger, 5-15% of radix scrophulariae, 7-16% of dark plum, 5-15% of radix glehniae, 5-15% of polygonatum kingianum (steamed), 5-15% of white atractylodes rhizome (stir-baked), 5-16% of hawthorn (stir-baked), 5-15% of semen cuscutae (wrap-decocted), 4-12% of bamboo shavings, 5-15% of reed rhizome, 5-15% of dandelion, 5-15% of citrus aurantium, 4-12% of dendrobium, 5-15% of radix ophiopogonis, 4-12% of mint, 5-15% of white peony root, and 4-12% of licorice. The beneficial effects of the traditional Chinese medicine preparation are as follows: either in the dose form of capsules or granules, the traditional Chinese medicine preparation has an exact and significant curative effect for the treatment of chronic superficial gastritis and atrophic gastritis, and is widespread in clinical use, safe and non-toxic side effects; and an appropriate extension of the treatment course of the preparation helps to improve the curative effect on chronic gastritis, so the traditional Chinese medicine preparation is a major breakthrough in traditional Chinese medicines for treatment of chronic gastritis.

The invention belongs to the field of traditional Chinese medicines for treating chronic atrophic gastritis. A traditional Chinese medicine composition disclosed by the invention mainly comprises the following raw materials in parts by weight: 8-15 parts of pilose Asiabell root, 8-15 parts of membranous milkvetch root, 8-15 parts of stir-fried largehead atractylodes rhizome, 8-15 parts of Indian buead, 10-20 parts of Chinese sage herb, 10-20 parts of glabrous greenbrier rhizome, 10-20 parts of raw coix seed, 10-20 parts of radix salviae miltiorrhizae, 8-15 parts of costustoot, 8-15 parts of caulis perllae, 8-15 parts of charred hawthorn fruit, 8-15 parts of medicated leaven and 5-10 parts of raw liquoric root. The traditional Chinese medicine syndrome comprehensive curative effects of clinical 40 cases of patients are as follows: clinical 20 cases are cured, 5 cases produce effects, 11 cases are effective, and the total effective rate is 90.0%. The endoscopic pathological comprehensive curative effects are as follows: clinical 16 cases are cured, 2 cases produce effects, 7 cases are effective, and the total effective rate is 62.5%. The traditional Chinese medicine composition disclosed by the invention has the effects of tonifying qi, activating spleen, eliminating dampness, dredging channels and the like, and has the advantages of short treatment course, significant curative effects and no toxic or side effects.